Gapping up
In reaction to strong earnings/guidance:
- GH +24.9%, WW +22.3%, SEDG +20.4%, MR +18.3%, NVTA +18%, MTCH +17.1%, FLXN +14.9%, GWPH +12.4%, LC +11.5%, PE +10.3%, DNR +8.8%, SAIL +8.7%, TXMD +8%, HUBS +7.9%, HTZ +6.4%, MODN +6.3% (ticking higher; also upgraded to Buy at Needham), ICPT +5.5%, HCR +5.3%, WK +5.1% (light volume), CVS +5.1%, BOLD +4.6%, HL +4.5%, NDLS +4.3% (light volume), MCHP +4.3%, BTG +4.3%, CPE +3.9%, AMN +3%, CPRI +2.9% (light volume), ODP +2.9%, PAA +2.7%, CYBR +2.3%, IONS +2.3% (also Akcea Therapeutics and Ionis Pharma announce that top-line results from the BROADEN study met the primary endpoint), TROX +2.2%, WEN +2.2%, FLT +2.1% (light volume), ARLO +1.9%
M&A news:
- CBM +47.8% (Cambrex to be acquired by affiliate of the Permira funds in a transaction valued at approximately $2.4 billion)
Solar related names showing strength on the heels of SolarEdge (SEDG) results:
- etf - TAN +3.2%, CSIQ +2%, SPWR +1.9%, RUN +1.8%, FSLR +1.7%, ENPH +1.3%
Select metals/mining stocks trading higher:
- AU +4.1%, EGO +3.6% (also filed $750 mln preliminary short form base shelf prospectus), KGC +3.5%, SLV +2.8%, GFI +2.8%, HMY +2.8%, GDX +2.5%, SBGL +2%, GOLD +2%, NEM +1.7%, GLD +1.4%
Other news:
- IAC +10.6% (following MTCH results - IAC owns 80% of the company)
- ALLK +5.1% (prices upsized offering of 4,545,454 shares at a public offering price of $77.00 per share)
- BYND +4.5% (ongoing volatility; also announces Subway partnership)
- GSKY +2.8% (modestly rebounding)
- NVS +2.5% (issues statement, says fully confident in safety, quality and efficacy of Zolgensma)
- PRGO +1.3% (ahead of earnings tomorrow)
- ETSY +1.1% (exec appearance on CNBC)
Analyst comments:
- MOS +1% (upgraded to Hold at CIBC)
- DNKN +0.8% (upgraded to Buy from Hold at Argus)
- PPL +0.7% (upgraded to Neutral from Underperform at BofA/Merrill)
- IFF +0.6% (upgraded to Overweight from Neutral at JPMorgan)